Stifel Maintains Buy on Inspire Medical Systems, Raises Price Target to $80
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsPrice Target
Stifel analyst Jonathan Block maintains Inspire Medical Systems (NYSE:INSP) with a Buy and raises the price target from $75 to $80.
Stifel analyst Jonathan Block maintains Inspire Medical Systems (NYSE:INSP) with a Buy and raises the price target from $75 to $80.